minoxidil has been researched along with latanoprost in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| El-Ashmawy, AA; El-Maadawy, IH; El-Maghraby, GM | 1 |
| Bergfeld, W; Murad, A | 1 |
| Cantelli, M; Fabbrocini, G; Napolitano, M; Nappa, P; Patruno, C; Vastarella, M | 1 |
| Cunha-Filho, M; França, LCF; Gelfuso, GM; Gratieri, T; Oliveira, PM; Sampaio, TR | 1 |
| Alencar-Silva, T; Carvalho, JL; Cunha-Filho, M; Gelfuso, GM; Gratieri, T; Oliveira, PM; Pires, FQ | 1 |
| Behrangi, E; Ghassemi, M; Goodarzi, A; Jafari, M; Yazdanian, N | 1 |
1 review(s) available for minoxidil and latanoprost
| Article | Year |
|---|---|
Treatment for facial alopecia areata: A systematic review with evidence-based analysis.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Alopecia Areata; Anthralin; Bimatoprost; Cyclopropanes; Dermatologic Agents; Drug Therapy, Combination; Eyebrows; Eyelashes; Facial Dermatoses; Humans; Latanoprost; Minoxidil; Photosensitizing Agents; Prostaglandins F, Synthetic | 2018 |
2 trial(s) available for minoxidil and latanoprost
| Article | Year |
|---|---|
Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia Areata; Betamethasone Valerate; Child; Child, Preschool; Female; Humans; Latanoprost; Male; Middle Aged; Minoxidil; Prostaglandins F, Synthetic; Recurrence; Single-Blind Method; Treatment Outcome; Young Adult | 2018 |
Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial.
Topics: Administration, Topical; Adult; Alopecia; Alopecia Areata; Betamethasone; Double-Blind Method; Female; Humans; Latanoprost; Male; Minoxidil; Ophthalmic Solutions; Patient Satisfaction; Personal Satisfaction; Treatment Outcome; Young Adult | 2022 |
5 other study(ies) available for minoxidil and latanoprost
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Allergic contact dermatitis probably caused by latanoprost during treatment for alopecia areata.
Topics: Administration, Cutaneous; Alopecia Areata; Dermatitis, Allergic Contact; Facial Dermatoses; Female; Humans; Latanoprost; Middle Aged; Minoxidil; Patch Tests; Scalp Dermatoses | 2019 |
LC-MS bioanalytical method for simultaneous determination of latanoprost and minoxidil in the skin.
Topics: Administration, Cutaneous; Animals; Calibration; Chromatography, Liquid; Latanoprost; Limit of Detection; Mass Spectrometry; Minoxidil; Reproducibility of Results; Skin; Swine | 2020 |
Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia.
Topics: Administration, Topical; Alopecia; Animals; Drug Delivery Systems; Hair Follicle; Humans; Latanoprost; Minoxidil; Swine | 2022 |